BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18497546)

  • 1. Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines.
    Kim MJ; Lee JC; Lee JJ; Kim S; Lee SG; Park SW; Sung MW; Heo DS
    Tumour Biol; 2008; 29(1):28-34. PubMed ID: 18497546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFNalpha2b stimulated release of IFNgamma differentially regulates T cell and NK cell mediated tumor cell cytotoxicity.
    Bose A; Baral R
    Immunol Lett; 2007 Jan; 108(1):68-77. PubMed ID: 17112599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7.
    Pries R; Wulff S; Kesselring R; Börngen K; Xie L; Wollenberg B
    Int J Oncol; 2008 Nov; 33(5):993-1000. PubMed ID: 18949362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
    Sung MW; Johnson JT; Van Dongen G; Whiteside TL
    Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells.
    Bhattacharya S; Muhammad N; Steele R; Kornbluth J; Ray RB
    Cancer Prev Res (Phila); 2017 Jun; 10(6):337-344. PubMed ID: 28465362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
    Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
    Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
    J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck.
    Sung MW; Yasumura S; Johnson JT; Van Dongen GA; Whiteside TL
    Int J Cancer; 1995 Jun; 61(6):864-72. PubMed ID: 7790123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell lysis of head and neck cancer.
    Racz T; Sacks PG; Taylor DL; Schantz SP
    Arch Otolaryngol Head Neck Surg; 1989 Nov; 115(11):1322-8. PubMed ID: 2679794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition.
    Crist M; Yaniv B; Palackdharry S; Lehn MA; Medvedovic M; Stone T; Gulati S; Karivedu V; Borchers M; Fuhrman B; Crago A; Curry J; Martinez-Outschoorn U; Takiar V; Wise-Draper TM
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36328378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity.
    Matsui M; Kishida T; Nakano H; Yoshimoto K; Shin-Ya M; Shimada T; Nakai S; Imanishi J; Yoshimoto T; Hisa Y; Mazda O
    Cancer Res; 2009 Mar; 69(6):2523-30. PubMed ID: 19244121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the change in cetuximab-induced antibody-dependent cellular cytotoxicity activity of natural killer cells by steroid.
    Kumai T; Oikawa K; Aoki N; Kimura S; Harabuchi Y; Kobayashi H
    Head Neck; 2016 Mar; 38(3):410-6. PubMed ID: 25352398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer.
    Schantz SP; Ordonez NG
    Nat Immun Cell Growth Regul; 1991; 10(5):278-88. PubMed ID: 1758468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha2b augments suppressed immune functions in tobacco-related head and neck squamous cell carcinoma patients by modulating cytokine signaling.
    Bose A; Ghosh D; Pal S; Mukherjee KK; Biswas J; Baral R
    Oral Oncol; 2006 Feb; 42(2):161-71. PubMed ID: 16249117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of circulating natural killer cells and T lymphocytes in head and neck squamous cell carcinoma.
    Böttcher A; Ostwald J; Guder E; Pau HW; Kramp B; Dommerich S
    Auris Nasus Larynx; 2013 Apr; 40(2):216-21. PubMed ID: 22835730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
    Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL
    Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.